Zobrazeno 1 - 10
of 102
pro vyhledávání: '"J L, Pico"'
Autor:
Giovanni Rosti, Anja Lorch, Jean-Pierre Droz, Karim Fizazi, Andrew Kramar, Joerg T. Hartmann, J. L. Pico, Jörg Beyer, Christophe Massard
Publikováno v:
Annals of Oncology. 24:322-328
Background: An early serum tumor marker (TM) decline during chemotherapy was shown to independently predict survival in patients with poor-prognosis disseminated non-seminomatous germ-cell tumors (NSGCTs). The aim of this study was to assess whether
Autor:
Nathalie Lassau, Hartmann O, J L Pico, E Benhamou, Jérome Leclère, J H Bourhis, Anne Auperin, Dominique Valteau-Couanet, Alain Roche, A Ibrahim, Jacques Bosq, T. Girinski
Publikováno v:
Radiology. 204:545-552
To determine the value of gray-scale ultrasonography (US) and Doppler US in the prediction, diagnosis, and prognostic assessment of hepatic veno-occlusive disease (HVOD).One hundred patients (median age, 22 years; range, 18 months to 59 years) receiv
Autor:
G, Michel, G, Socié, F, Gebhard, F, Bernaudin, I, Thuret, J P, Vannier, F, Demeocq, G, Leverger, J L, Pico, H, Rubie, F, Mechinaud, J, Reiffers, N, Gratecos, X, Troussard, J P, Jouet, G, Simonin, E, Gluckman, D, Maraninchi
Publikováno v:
Journal of Clinical Oncology. 15:2238-2246
PURPOSE To evaluate growth, thyroid function, puberty, cardiac function, and the incidence of cataracts in children who received allogeneic bone marrow transplantation (BMT) for acute myeloblastic leukemia (AML) in first complete remission (CR) after
Autor:
H. J. Schmoll, Craig R. Nichols, J. P. Droz, Wolfgang Siegert, Werner Linkesch, J L Pico, A Diehl, A Kramar, Jörg Beyer, Lawrence H. Einhorn, C Bokemeyer, A Greinix, R Mandanas
Publikováno v:
Scopus-Elsevier
PURPOSE To identify prognostic variables for response and survival in male patients with relapsed or refractory germ cell tumors treated with high-dose chemotherapy (HDCT) and hematopoietic progenitor cell support. PATIENTS AND METHODS Three hundred
Autor:
J L Pico, M Casetta, B. Leclercq, Bernard Escudier, Marguerite Guiguet, Gérard Nitenberg, François Blot, Sami Antoun
Publikováno v:
Intensive Care Medicine
Objective To evaluate the safety of tracheotomy in neutropenic ventilated cancer patients, in terms of infectious and haemorrhagic complications. Design Retrospective study. Setting A medical-surgical intensive care unit in a Cancer-hospital.Patients
Autor:
Sandrine Prost, S Bodis, J Bosq, M Hayat, J Benard, J L Pico, A M Venuat, P Y Dietrich, L Ramirez, P Ardouin, P Mauch
Publikováno v:
University of Edinburgh-PURE
In order to investigate the biology of tumor cells which express MDR1 gene and to test the activity of different P-glycoprotein blocking agents in vivo, we established a nude mice model. Five Non Hodgkin's Lymphoma (NHL) tumor specimens were xenograf
Autor:
D, Blaise, M, Attal, J, Reiffers, M, Michallet, C, Bellanger, J L, Pico, A M, Stoppa, C, Payen, G, Marit, R, Bouabdallah, J J, Sotto, J F, Rossi, M, Brandely, T, Hercend, D, Maraninchi
Publikováno v:
European cytokine network. 11(1)
Immunological control of acute leukemia may be achieved after allogeneic transplant. Despite promising preliminary results, the impact of immunotherapy with interleukin-2 (r-IL-2) on patients with acute leukemia (AL), in first complete remission (CR1
Autor:
V. Lapierre, M. Hayat, P. H. Lagrange, C. Maulard, M. Pappo, J L Pico, Antoine Andremont, Zittoun R, D. Chiche, Marie Jp
Publikováno v:
Médecine et Maladies Infectieuses. 21:386-388
Resume Les resultats d'un protocole de traitement empirique de 223 episodes febriles chez le neutropenique montrent 1) que la frequence des septicemies inaugurales a germes a Gram positif atteint 50 %, 2) que l'indication de la vancomycine ne peut at
Autor:
B, Coiffier, E M, Neidhardt-Bérard, H, Tilly, C, Belanger, R, Bouabdallah, C, Haioun, P, Brice, P Y, Péaud, J L, Pico, M, Janvier, P, Solal-Celigny, N, Brousse
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 10(10)
Fludarabine was associated with a good response and was well tolerated in patients with follicular lymphoma in phase II trials and this treatment may be associated with less adverse events than treatment with CHVP plus interferon in elderly patients.
Autor:
M, André, M, Henry-Amar, J L, Pico, P, Brice, D, Blaise, M, Kuentz, B, Coiffier, P, Colombat, J Y, Cahn, M, Attal, J, Fleury, N, Milpied, G, Nedellec, P, Biron, H, Tilly, J P, Jouet, C, Gisselbrecht
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 17(1)
To determine the prognostic factors and outcome of first-line induction failure Hodgkin's disease patients who were treated with a salvage regimen of high-dose chemotherapy and autologous stem-cell transplantation, and to compare them with matched, c